当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • 索引コペルニクス
  • Google スカラー
  • シェルパ・ロミオ
  • Genamics JournalSeek
  • セーフティライト付き
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

Smoking-related Attitudes, Behaviors and Cessation Efforts among Coronary Heart Disease Patients in Hungary

Haddad L, Bakai J, Ghadban R, Ferrell A

Background: Smoking is a serious public health problem in Hungary, where at least 25% of people smoke daily and cardiovascular disease (CVD) is a leading cause of mortality of older adults. Smoking cessation is the most effective way to prevent cardiovascular disease, but many patients with CVD continue smoking after hospital discharge.
Objective: The purpose of this study was to reveal the factors, including demographics, socioeconomic status, and psychosocial barriers, that are related to persistent smoking after a diagnosis of coronary heart disease (CHD), a type of CVD.
Methodology: This study used a descriptive cross-sectional design and included 315 cardiac patients engaged in a comprehensive, outpatient cardiological rehabilitation (CR) program in Sopron, Hungary. All patients were diagnosed with coronary heart disease (CHD) at least 6 months prior to study commencement. Data were collected at the 3rd week of admission for the inpatient sample and after 12 weeks of discharge for the outpatient sample.
Results: The study sample consisted of smokers (54%), former smokers (25%), and nonsmokers (21%). Smokers had a significant reduction in cigarettes smoked after the CHD diagnosis (22 vs. 14, p<0.05). Negative health effects (n=225), doctor’s orders (n=205), and cigarette cost (n=173) were the main self-reported reasons for smoking reduction. The biggest barriers to smoking cessation were missing of cigarettes (M=2.9; SD=1.6), withdrawal symptoms (M=2.8, SD=1.4), weight gain (M=2.4, SD=1.6), fear of failing to quit (M=2.2, SD=1.5), and encouragement from family members to smoke (M=2.2, SD=1.5). In regression model for barriers to cessation, social support significantly predicted perceived barriers (t=-2.53, p=0.0121*), emotional wellbeing (t=-2.21, p=0.0280*), work stress (t=3.01, p=0.0029*), and household stress (t=2.55, p=0.0114*). In regression models for desire and confidence to quit smoking, social support significantly predicted desire (t=2.66, p=0.0086*) and confidence (t=3.75, p=0.0002*) to quit smoking.
Conclusion: Given these findings, it is likely that nicotine dependence plays a strong role in persistent tobacco use after CHD diagnosis. These findings support those of other similar studies and may lead to the development of effective cessation interventions for patients who smoke and suffer from cardiovascular disease.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。